Astellas Pharma (South Korea)

Astellas Pharma (South Korea)

Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Astellas Pharma (South Korea), South Korea, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

79%


Total
Publications

53


Total Open
Publications

42


Total
Citations

411


Open Access
Percentage

79%


Total
Publications

53


Total Open
Publications

42


Total
Citations

411

Wikipedia

Website

download

Breakdown

49% 30% 0% 21%

Publisher Open

49%

Both

30%

Other Platform Open

0%

Closed

21%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0123456789Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

38%OA Journal

OA Journal 38%

16

Hybrid 36%

15

No Guarantees 26%

11

Other Platform Open

Domain 56%

9

Institution 44%

7

Public 25%

4

Other Internet 25%

4

Preprint 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
9
Europe PMC
Domain
6
Semantic Scholar
Public
4
Yonsei University Medical Library - YUHSpace
Institution
3
Unknown Repository
Other Internet
2
Universidad de la Rioja - Dialnet
Institution
2
University of Oxford - Oxford Academic Notes & Queries
Institution
1
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Other Internet
1
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Institution
1
OpenEdition - OpenEdition
Institution
1
1 / 2

Data updated 13 August 2024

Share

Share

Share